A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

New ‘unusual’ side effect of weight-loss drugs becoming more common, research suggests - GLP-1 drugs may interfere with ...

GLP-RAs significantly improved liver histology, liver fat, and metabolic markers in patients with MASLD, outperforming DDP-4 inhibitors but increasing mild GI side effects.

Glucagon-like peptide-1 receptor (GLP-1) agonist medications have become increasingly popular thanks to their effectiveness for weight loss and blood sugar management. To get these medications, you ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research ...

In a state where the obesity rate ranks among the highest in the country, many health providers were thrilled when ...

A doctor has issued a warning over a worrying new side effect of drugs used to aid weight loss. Drugs such as Mounjaro, ...

UK researchers warn GLP-1 drugs like Ozempic may cause misleading PET-CT results, risking misdiagnosis of cancer or ...

A newly identified side effect of popular weight-loss drugs such as Ozempic and Wegovy may interfere with medical imaging and ...